Cargando…
Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599890/ https://www.ncbi.nlm.nih.gov/pubmed/36291049 http://dx.doi.org/10.3390/bios12100794 |
_version_ | 1784816704891650048 |
---|---|
author | Yu, Albert Dai, Xiaoyong Wang, Zixian Chen, Huaqing Guo, Bing Huang, Laiqiang |
author_facet | Yu, Albert Dai, Xiaoyong Wang, Zixian Chen, Huaqing Guo, Bing Huang, Laiqiang |
author_sort | Yu, Albert |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9599890 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95998902022-10-27 Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109 Yu, Albert Dai, Xiaoyong Wang, Zixian Chen, Huaqing Guo, Bing Huang, Laiqiang Biosensors (Basel) Correction MDPI 2022-09-27 /pmc/articles/PMC9599890/ /pubmed/36291049 http://dx.doi.org/10.3390/bios12100794 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Correction Yu, Albert Dai, Xiaoyong Wang, Zixian Chen, Huaqing Guo, Bing Huang, Laiqiang Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109 |
title | Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109 |
title_full | Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109 |
title_fullStr | Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109 |
title_full_unstemmed | Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109 |
title_short | Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109 |
title_sort | correction: yu et al. recent advances of mesoporous silica as a platform for cancer immunotherapy. biosensors 2022, 12, 109 |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599890/ https://www.ncbi.nlm.nih.gov/pubmed/36291049 http://dx.doi.org/10.3390/bios12100794 |
work_keys_str_mv | AT yualbert correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapybiosensors202212109 AT daixiaoyong correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapybiosensors202212109 AT wangzixian correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapybiosensors202212109 AT chenhuaqing correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapybiosensors202212109 AT guobing correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapybiosensors202212109 AT huanglaiqiang correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapybiosensors202212109 |